Induction of Angiogenesis in Omentum with Vascular Endothelial Growth Factor: Influence on the Viability of Encapsulated Rat Pancreatic Islets during Transplantation

Transplantation of pancreatic islets is proposed as a treatment for type 1 diabetes, but insufficient blood supply can cause the loss of viable grafted islets. In the present study, we investigated the influence of vascular endothelial growth factor (VEGF) on the angiogenesis of omentum during encapsulated islet allotransplantation and consequently on islet survival. Fifty rat islets, cultured for 24 h, were encapsulated in the presence or absence of human VEGF and implanted in the peritoneal cavity of rats (n = 6). After 7, 14 and 28 days of implantation, encapsulation devices with surrounding omentum were removed. Histological analysis of this tissue was performed. Cellular adhesion at the membrane surface was characterized by a phagocytosis test. The morphological aspect of the islets was analyzed and their functionality was evaluated by measuring insulin secretion. At each step of the study, there was a two-fold increase in the number of vessels in the presence of VEGF. In addition, VEGF increased the vessel diameter and the surface area of the angiogenic pedicle. Moreover, the presence of VEGF significantly decreased the distance between the devices and vessels (16.2 ± 5.6 vs. 51.6 ± 10.1 µm, p < 0.001). Membrane surface analysis showed a decrease in macrophage adhesion in the presence of VEGF. Furthermore, islet structure and functionality was preserved in the presence of VEGF. Stimulation of angiogenesis of omentum induced by VEGF is associated with preservation of islet viability. Local delivery of VEGF proved to be a relevant approach to ameliorate the outcome of islet transplantation.

[1]  F. Ris,et al.  Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999–2000) , 2001, Diabetologia.

[2]  J F Elliott,et al.  Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. , 2001, Diabetes.

[3]  M Freund,et al.  Quantitative image analysis of angiogenesis in rats implanted with a fibrin gel chamber. , 1992, Nouvelle revue francaise d'hematologie.

[4]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[5]  Wei Li,et al.  VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. , 1999, Experimental cell research.

[6]  R. James,et al.  Bovine serum albumin density gradient isolation of rat pancreatic islets. , 1987, Transplantation.

[7]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .

[8]  S. Sumi,et al.  Immunohistochemical Studies on Vascular Endothelial Growth Factor and Platelet Endothelial Cell Adhesion Molecule-1/CD-31 in Islet Transplantation , 2000, Pancreas.

[9]  D. Power,et al.  Vascular endothelial growth factor is a survival factor for renal tubular epithelial cells. , 2000, American journal of physiology. Renal physiology.

[10]  M. Welsh,et al.  Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro , 1997, Molecular and Cellular Endocrinology.

[11]  L. Aiello,et al.  Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. , 1998, Diabetes.

[12]  S. Bunting,et al.  Vascular endothelial growth factor, a specific regulator of angiogenesis , 1996, Current opinion in nephrology and hypertension.

[13]  O. Korsgren,et al.  Ultrastructural evidence for blood microvessels devoid of an endothelial cell lining in transplanted pancreatic islets. , 1995, The American journal of pathology.

[14]  P. Lacy.  Pancreatic islet cell transplant. , 1994, The Mount Sinai journal of medicine, New York.

[15]  S. Bonner-Weir,et al.  Vulnerability of Islets in the Immediate Posttransplantation Period: Dynamic Changes in Structure and Function , 1996, Diabetes.

[16]  H. Lehr,et al.  Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. , 1995, The American journal of pathology.

[17]  K. Messmer,et al.  Orientation of microvascular blood flow in pancreatic islet isografts. , 1994, The Journal of clinical investigation.

[18]  L. Orci,et al.  New Perspectives on the Microvasculature of the Islets of Langerhans in the Rat , 1982, Diabetes.

[19]  L. Orci,et al.  Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. , 1997, Transplantation.

[20]  W. Rau,et al.  Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management , 1999, Journal of Molecular Medicine.

[21]  P. Lacy,et al.  Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas , 1967, Diabetes.

[22]  E. Samols,et al.  Hormone secretion from transplanted islets is dependent upon changes in islet revascularization and islet architecture. , 1995, Transplantation proceedings.

[23]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[24]  G. Steil,et al.  Improved Vascularization of Planar Membrane Diffusion Devices following Continuous Infusion of Vascular Endothelial Growth Factor , 2000, Cell transplantation.

[25]  S. Bonner-Weir,et al.  Islets of Langerhans: the puzzle of intraislet interactions and their relevance to diabetes. , 1990, The Journal of clinical investigation.

[26]  D. Connolly,et al.  Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration , 1990, The Journal of experimental medicine.

[27]  S. Mori,et al.  Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells. , 1995, The Journal of clinical endocrinology and metabolism.

[28]  E. Samols,et al.  The induction of capillary bed development by endothelial cell growth factor before islet transplantation may prevent islet ischemia. , 1990, Transplantation proceedings.

[29]  C. Colton,et al.  Effect of Hypoxia on Insulin Secretion by Isolated Rat and Canine Islets of Langerhans , 1993, Diabetes.

[30]  V. Karsten,et al.  Chemotaxis Activation of Peritoneal Murine Macrophages Induced by the Transplantation of Free and Encapsulated Pancreatic Rat Islets , 2000, Cell transplantation.

[31]  C. Ricordi,et al.  Long-Term Function (6 Years) of Islet Allografts in Type 1 Diabetes , 1997, Diabetes.